Identification and Validation of HOTAIRM1 as a Novel Biomarker for Oral Squamous Cell Carcinoma

• Published in: Frontiers in bioengineering and biotechnology Vol. 9; p. 798584
• Main Authors: Yu, Yixiu, Niu, Jiamei, Zhang, Xingwei, Wang, Xue, Song, Hongquan, Liu, Yingqun, Jiao, Xiaohui, Chen, Fuyang
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 11-01-2022
• Subjects: Bioengineering and Biotechnology; biomarker; cell cycle; cell proliferation; lncRNA HOTAIRM1; oral squamous cell carcinoma; oral squamous cell carcinoma; cell proliferation; biomarker; cell cycle; lncRNA HOTAIRM1
• ISSN: 2296-4185; 2296-4185
• DOI: 10.3389/fbioe.2021.798584

ORAL squamous cell carcinoma (OSCC) is a malignant tumor with the highest incidence among tumors involving the oral cavity maxillofacial region, and is notorious for its high recurrence and metastasis potential. Long non-coding RNAs (lncRNAs), which regulate the genesis and evolution of cancers, are potential prognostic biomarkers. This study identified HOTAIRM1 as a novel significantly upregulated lncRNA in OSCC, which is strongly associated with unfavorable prognosis of OSCC. Systematic bioinformatics analyses demonstrated that HOTAIRM1 was closely related to tumor stage, overall survival, genome instability, the tumor cell stemness, the tumor microenvironment, and immunocyte infiltration. Using biological function prediction methods, including Weighted gene co-expression network analysis (WGCNA), Gene set enrichment analysis (GSEA), and Gene set variation analysis (GSVA), HOTAIRM1 plays a pivotal role in OSCC cell proliferation, and is mainly involved in the regulation of the cell cycle.
, cell loss-functional experiments confirmed that HOTAIRM1 knockdown significantly inhibited the proliferation of OSCC cells, and arrested the cell cycle in G1 phase. At the molecular level, PCNA and CyclinD1 were obviously reduced after HOTAIRM1 knockdown. The expression of p53 and p21 was upregulated while CDK4 and CDK6 expression was decreased by HOTAIRM1 knockdown.
, knocking down HOTAIRM1 significantly inhibited tumor growth, including the tumor size, weight, volume, angiogenesis, and hardness, monitored by ultrasonic imaging and magnetic resonance imaging In summary, our study reports that HOTAIRM1 is closely associated with tumorigenesis of OSCC and promotes cell proliferation by regulating cell cycle. HOTAIRM1 could be a potential prognostic biomarker and a therapeutic target for OSCC.